Screening for hepatitis A and B antibodies in patients with chronic liver disease

American Journal of Medicine

Volumn 118, Issue 10 SUPPL., 2005, Pages 28-33

  Lau, Daryl T Y ^a,b   Hewlett, Alex T ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Antibody; Chronic liver disease; Hepatitis A virus; Hepatitis B virus; Hepatitis C virus; Screening

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G ANTIBODY;

ACUTE HEPATITIS; ADULT; ADULTHOOD; AFRICAN AMERICAN; AGE DISTRIBUTION; ANTIBODY SCREENING; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EXPOSURE; FATALITY; FOLLOW UP; HEALTH STATUS; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; IMMUNITY; INFECTION PREVENTION; LABORATORY TEST; LIVER INJURY; MEDICAL SOCIETY; PATHOGENESIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE; REVIEW; SEROCONVERSION; SEROLOGY; STANDARDIZATION; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 27644460284     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.07.014     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention Deaths and hospitalizations from chronic liver disease and cirrhosis - United States, 1980-1989 MMWR Morb Mortal Wkly Rep 41 1993 969 973
2. Centers for Disease Control and Prevention Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease MMWR Recomm Rep 47 RR-19 1998 1 39
3. M.J. Alter, D. Kruszon-Moran, O.V. Nainan The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 1999 556 562
4. S. Vento, T. Garofano, C. Renzini Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C N Engl J Med 338 1998 286 290
5. C. Feray, M. Gigou, D. Samuel Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis Gastroenterology 104 1993 549 555
6. J.P. Zarski, B. Bohn, A. Bastie Characteristics of patients with dual infection by hepatitis B and C viruses J Hepatol 28 1998 27 33
7. Centers for Disease Control and Prevention Prevention of hepatitis A through active or passive immunization recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 48 RR-12 1999 1 37
8. World Health Organization. Hepatitis A. Available at: http://www.who.int/csr/disease/hepatitis/HepatitisA_whocdscsredc2000_7.pdf. Accessed June 13, 2005.
9. National Institutes of Health Management of Hepatitis C NIH Consensus US Statement 15 1997 1 46
10. E.B. Keeffe, S. Iwarson, B.J. McMahon Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease Hepatology 27 1998 881 886
11. G.A. Smallwood, C.T. Coloura, E. Martinez, A.C. Stieber, T.G. Heffron Can patients awaiting liver transplantation elicit an immune response to the hepatitis A vaccine? Transplant Proc 34 2002 3289 3290
12. J.A. Dumot, D.S. Barnes, Z. Younossi Immunogenicity of hepatitis A vaccine in decompensated liver disease Am J Gastroenterol 94 1999 1601 1604
13. M.R. Arguedas, A. Johnson, M.A. Eloubeidi, M.B. Fallon Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients Hepatology 34 2001 28 31
14. S.D. Lee, C.Y. Chan, M.I. Yu, R.H. Lu, F.Y. Chang, K.J. Lo Hepatitis B vaccination in patients with chronic hepatitis C J Med Virol 59 1999 463 468
15. C. Mendenhall, G.A. Roselle, L.A. Lybecker Hepatitis B vaccination response of alcoholic with and without liver injury [erratum appears in Dig Dis Sci. 1994;39:224] Dig Dis Sci 33 1988 263 269
16. J.P. Bronowicki, F. Weber-Larivaille, J.P. Gut, M. Doffoel, D. Vetter Comparison of immunogenicity of vaccination and serovaccination against hepatitis B virus in patients with alcoholic cirrhosis [in French] Gastroenterol Clin Biol 21 1997 848 853
17. G. Reiss, E.B. Keeffe Hepatitis vaccination in patients with chronic liver disease Aliment Pharmacol Ther 19 2004 715 727
18. Centers for Disease Control and Prevention. Disease burden from hepatitis A, B, and C in the United States. Available at: http://www.cdc.gov/ncidod/ diseases/hepatitis/resource/pdfs/disease_burden2004.pdf. Accessed June 13, 2005.
19. F. Siddiqui, M. Mutchnick, J. Kinzie, R. Peleman, P. Naylor, M. Ehrinpreis Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C implication for vaccination strategy Am J Gastroenterol 96 2001 858 863
20. S.A. Villano, K.E. Nelson, D. Vlahov, R.H. Purcell, A.J. Saah, D.L. Thomas Hepatitis A among homosexual men and injection drug users more evidence for vaccination Clin Infect Dis 25 1997 726 728
21. M. Duncan, W.K. Hirota, A. Tsuchida Prescreening versus empirical immunization for hepatitis A in patients with chronic liver disease a prospective cost analysis Am J Gastroenterol 97 2002 1792 1795
22. R.J. Jacobs, R.S. Koff, A.S. Meyerhoff The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A Am J Gastroenterol 97 2002 427 434
23. M.H. Sjogren Preventing acute liver disease in patients with chronic liver disease Hepatology 27 1998 887 888
24. S. Saab, P. Martin, H.F. Yee Jr A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination Am J Med 109 2000 241 244
25. G.M. McQuillan, P.J. Coleman, D. Kruszon-Moran, L.A. Moyer, S.B. Lambert, H.S. Margolis Prevalence of hepatitis B virus infection in the United States the National Health and Nutrition Examination Surveys, 1976 through 1994 Am J Public Health 89 1999 14 18
26. Centers for Disease Control and Prevention Protection against viral hepatitis recommendations of the Immunization Practices Advisory Committee (ACIP) MMWR Recomm Rep 39 RR-2 1990 1 26
27. U.S. Preventive Services Task Force. Brief Evidence Update: Screening for Hepatitis B Virus Infection. Available at: http://www.ahrq.gov/clinic/ 3rduspstf/hepbscr/hepbup.htm. Accessed June 13, 2005.
28. National Task Force for Hepatitis B: Focus on Asian and Pacific Islander Americans. Available at: http://www.hepbinitiative.org/taskforce/index.html. Accessed on August 3, 2005.
29. A.S. Yu, R.C. Cheung, E.B. Keeffe Hepatitis B vaccines Clin Liver Dis 8 2004 283 300
30. B. Weber, W. Melchior, R. Gehrke, H.W. Doerr, A. Berger, H. Rabenau Hepatitis B virus markers in anti-HBc only positive individuals J Med Virol 64 2001 312 319
31. R.B. Schifman, S.L. Rivers, R.E. Sampliner, J.E. Krammes Significance of isolated hepatitis B core antibody in blood donors Arch Intern Med 153 1993 2261 2266
32. C.-J. Chen Time-dependent events in natural history of occult hepatitis B virus infection the importance of population-based long-term follow-up study with repeated measurements [editorial] J Hepatol 42 2005 438 440
33. G.Y. Minuk, D.-F. Sun, J. Uhanova Occult hepatitis B virus infection in a North American community-based population J Hepatol 42 2005 480 485
34. K.Q. Hu Occult hepatitis B virus infection and its clinical implications J Viral Hepat 9 2002 243 257
35. A.A. Wagner, F. Denis, P. Weinbreck Serological pattern 'anti-hepatitis B core alone' in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants AIDS 18 2004 569 571
36. J. Blostein, P.A. Clark Cost-effectiveness of preimmunization hepatitis B screening in high-risk adolescents Public Health Rep 116 2001 165 168
37. C.L. Lai, J.Y. Lau, E.K. Yeoh, W.K. Chang, H.J. Lin Significance of isolated anti-HBc seropositivity by ELISA implications and the role of radioimmunoassay J Med Virol 36 1992 180 183
38. M. Wiedmann, U.G. Liebert, U. Oesen Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C Hepatology 31 2000 230 234
39. E.B. Keeffe, D.S. Krause Hepatitis B vaccination of patients with chronic liver disease Liver Transpl Surg 4 1998 437 439
40. B. Kallinowski, W. Jilg, L. Buchholz, W. Stremmel, S. Engler Immunogenicity of an accelerated vaccination regime with a combined hepatitis A/B vaccine in patients with chronic hepatitis C Z Gastroenterol 41 2003 983 990